| Early failure | P value | ||||
| No (n = 80) | Yes (n = 20) | ||||
| No. | % | No. | % | ||
| Age | |||||
| <40 years | 38 | 47.5 | 9 | 45 | 0.592 |
| ≥40 years | 42 | 52. 5 | 11 | 55 | |
| Gender |
|
|
|
| |
| Male | 42 | 40.0 | 10 | 50 | 0.706 |
| Female | 38 | 60.0 | 10 | 50 | |
| Site |
|
|
|
| |
| Colon | 61 | 67.5 | 13 | 65 | 0.779 |
| Rectum | 19 | 32.5 | 7 | 35 | |
| Pathology |
|
|
|
| |
| Adenocarcinoma | 72 | 75 | 14 | 70 | 0.280 |
| Other variants | 8 | 25 | 6 | 30 | |
| Grade |
|
|
|
| |
| Well diff | 18 | 57.5 | 6 | 30 | 0.229 |
| Mod diff | 24 | 36.25 | 8 | 40 | |
| Poorly diff | 24 | 6.25 | 6 | 30 | |
| Tumor invasion |
|
|
|
|
|
| T2 | 9 | 12.5 | 5 | 25 | 0.002* |
| T3 | 66 | 80.0 | 4 | 20 | |
| T4 | 5 | 7.5 | 11 | 50 | |
| Lymph node status |
|
|
|
|
|
| N1 | 43 | 56.25 | 9 | 45 | 0.249 |
| N2 | 37 | 43.75 | 11 | 55 | |
| CEA |
|
|
|
| |
| Normal | 53 | 75 | 5 | 25 | 0.041* |
| Abnormal | 27 | 25 | 15 | 75 | |
| ERCC1 |
|
|
|
| |
| Positive | 5 | 12.5 | 16 | 80 | 0.004* |
| Negative | 75 | 87.5 | 4 | 20 | |